Menu
Recruiting NCT06136572

Epidemiology of Assertiveness and Emotion Management Disorders in People With Tourette's Syndrome

No phase Interventional Tourette Syndrome

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Rathus Assertiveness scale.
Who it may be relevant to
Registry conditions: Tourette Syndrome. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

The goal of this study is to evaluate the proportion of assertiveness difficulties in Tourette syndrome. Participants will complete several e-questionnaires (on assertiveness, Tourette severity, quality of life, self-esteem and comorbidities like depression, anxiety...).

Interventions

  • Diagnostic test Rathus Assertiveness scale
    Questionnaire completion

Primary outcome measures

  • Rathus assertiveness questionnaire [Time frame: 5 minutes at inclusion]
Secondary outcome measures (6)
  • MOVES [Time frame: less than 5 minutes at inclusion]
  • HADS [Time frame: 3 minutes at inclusion]
  • ASRS-5 [Time frame: 2 minutes at inclusion]
  • Rosenberg Self-Esteem Scale [Time frame: 2-3 minutes at inclusion]
  • DERS [Time frame: 5 minutes at inclusion]
  • GTS-QoL [Time frame: 5 minutes at inclusion]

Eligibility criteria

Inclusion criteria

  • Tourette syndrome
  • Participants aged 18 years or over

Exclusion criteria

  • Participants under legal protection
  • Inability to complete questionnaires alone

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Diagnostic

Study locations

France · 1 center
  • CHU Clermont-Ferrand — Clermont-Ferrand

Identifiers

NCT: NCT06136572 · RNI 2023 JALENQUES

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗